This nomogram was designed to be used by physicians and people with renal cell carcinoma.
Mskcc renal cell carcinoma risk stratification.
The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail.
Our kidney cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for newly diagnosed renal cell carcinoma a type of kidney cancer.
Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis.
If you are a patient we recommend that you use this tool in consultation with your.
Who can use this tool.
The two scores of 5 respectively 7 items are the only clinical judgment tools that address survival of patients with metastatic renal cell carcinoma.
Motzer md is a medical oncologist at memorial sloan kettering cancer center.
He received the career development award from the national institutes of health and the schonfeld award from the kidney cancer association.
Motzer s research focuses on renal cell carcinoma germ cell tumors and bone marrow and blood cell.